BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Savoia C, Volpe M, Kreutz R. Hypertension, a Moving Target in COVID-19: Current Views and Perspectives. Circ Res 2021;128:1062-79. [PMID: 33793331 DOI: 10.1161/CIRCRESAHA.121.318054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liang X, Chou OHI, Cheung CL, Cheung BMY. Is hypertension associated with arthritis? The United States national health and nutrition examination survey 1999-2018. Ann Med 2022;54:1767-75. [PMID: 35786117 DOI: 10.1080/07853890.2022.2089911] [Reference Citation Analysis]
2 El-kady AM, Aldakheel FM, Allemailem KS, Almatroudi A, Dbas Alharbi R, Al Hamed H, Alsulami M, Alshehri WA, El-ashram S, Kreys E, Mohamed K, Al-megrin WAI, Elshabrawy HA. . IJGM 2022;Volume 15:6945-63. [DOI: 10.2147/ijgm.s374090] [Reference Citation Analysis]
3 Mal P, Mukherjee T, Upadhyay AK, Mohanty S, Pattnaik AK. Connecting the dots between inflammatory cascades of obesity and COVID-19 in light of mortal consequences-a review. Environ Sci Pollut Res Int 2022. [PMID: 35731430 DOI: 10.1007/s11356-022-21461-x] [Reference Citation Analysis]
4 Larsson E, Eriksson J, Eriksson M, Oldner A. Critical Influenza and COVID-19—A Comparative Nationwide Case-Control Study. Critical Care Explorations 2022;4:e0705. [DOI: 10.1097/cce.0000000000000705] [Reference Citation Analysis]
5 Burnier M, Kjeldsen SE, Narkiewicz K, Egan B, Kreutz R. Hypertension management during the COVID-19 pandemic: what can we learn for the future? Blood Pressure 2022;31:47-9. [DOI: 10.1080/08037051.2022.2058909] [Reference Citation Analysis]
6 Carmona-Pírez J, Ioakeim-Skoufa I, Gimeno-Miguel A, Poblador-Plou B, González-Rubio F, Muñoyerro-Muñiz D, Rodríguez-Herrera J, Goicoechea-Salazar JA, Prados-Torres A, Villegas-Portero R. Multimorbidity Profiles and Infection Severity in COVID-19 Population Using Network Analysis in the Andalusian Health Population Database. Int J Environ Res Public Health 2022;19:3808. [PMID: 35409489 DOI: 10.3390/ijerph19073808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 de Medeiros SF, Yamamoto MMW, de Medeiros MAS, Yamamoto AKLW, Barbosa BB. Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review : PCOS and COVID-19 relationship. Rev Endocr Metab Disord 2022. [PMID: 35218458 DOI: 10.1007/s11154-022-09715-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gallo G, Calvez V, Savoia C. Hypertension and COVID-19: Current Evidence and Perspectives. High Blood Press Cardiovasc Prev 2022. [PMID: 35184271 DOI: 10.1007/s40292-022-00506-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Volpe M, Gallo G, Modena MG, Ferri C, Desideri G, Tocci G; Members of the Board of the Italian Society of Cardiovascular Prevention. Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention. High Blood Press Cardiovasc Prev 2022. [PMID: 35025091 DOI: 10.1007/s40292-021-00503-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Smith SM, Desai RA, Walsh MG, Nilles EK, Shaw K, Smith M, Chamberlain AM, Derington CG, Bress AP, Chuang CH, Ford DE, Taylor BW, Chandaka S, Patel LP, McClay J, Priest E, Fuloria J, Doshi K, Ahmad FS, Viera AJ, Faulkner M, O'Brien EC, Pletcher MJ, Cooper-DeHoff RM. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab. Am Heart J Plus 2022;13:100112. [PMID: 35252907 DOI: 10.1016/j.ahjo.2022.100112] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Singh B, Singh D, Verma V, Yadav R, Kumar R. Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review. J Pharm Anal 2021. [PMID: 34934510 DOI: 10.1016/j.jpha.2021.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wu J, Liu X, Shao J, Zhang Y, Lu R, Xue H, Xu Y, Wang L, Zhou H, Yu L, Yue M, Dong C. Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response. Virol J 2021;18:244. [PMID: 34876159 DOI: 10.1186/s12985-021-01717-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Clouston SAP, Luft BJ, Sun E. Clinical risk factors for mortality in an analysis of 1375 patients admitted for COVID treatment. Sci Rep 2021;11:23414. [PMID: 34862487 DOI: 10.1038/s41598-021-02920-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Gimeno-Miguel A, Bliek-Bueno K, Poblador-Plou B, Carmona-Pírez J, Poncel-Falcó A, González-Rubio F, Ioakeim-Skoufa I, Pico-Soler V, Aza-Pascual-Salcedo M, Prados-Torres A, Gimeno-Feliu LA; PRECOVID Group. Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study. PLoS One 2021;16:e0259822. [PMID: 34767594 DOI: 10.1371/journal.pone.0259822] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
15 Qu L, Chen C, Yin T, Fang Q, Hong Z, Zhou R, Tang H, Dong H. ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review. Int J Mol Sci 2021;22:11483. [PMID: 34768911 DOI: 10.3390/ijms222111483] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Battistoni A, Volpe M. Repurposing Cardio-Metabolic Drugs to Fight Covid19. High Blood Press Cardiovasc Prev 2021;28:419-23. [PMID: 34524680 DOI: 10.1007/s40292-021-00475-5] [Reference Citation Analysis]
17 Hakim A, Hasan MM, Hasan M, Lokman SM, Azim KF, Raihan T, Chowdhury PA, Azad AK. Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges. Front Microbiol 2021;12:637554. [PMID: 34512561 DOI: 10.3389/fmicb.2021.637554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Shibata S, Kishi T. Updates on renin-angiotensin system blockers in hypertensive patients with COVID-19. Am J Hypertens 2021:hpab130. [PMID: 34406353 DOI: 10.1093/ajh/hpab130] [Reference Citation Analysis]
19 Cooper SL, Boyle E, Jefferson SR, Heslop CRA, Mohan P, Mohanraj GGJ, Sidow HA, Tan RCP, Hill SJ, Woolard J. Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID. Int J Mol Sci 2021;22:8255. [PMID: 34361021 DOI: 10.3390/ijms22158255] [Cited by in F6Publishing: 9] [Reference Citation Analysis]